Congo to receive 70K doses of Ervebo Ebola vaccine used in past outbreaks
The Ervebo vaccine is licensed for use against Ebola virus, one of the viruses that cause Ebola disease, but not for Bundibugyo virus.
Global News
First coverage
Compiled by CurrentWire News Desk
Summary based on reporting from Global News.
Automated coverage analysis
Generated automatically from the coverage listed on this page. CurrentWire adds no editorial claims.
Coverage
1 publication is covering this story.
How CurrentWire compiled this story
Global News (globalnews.ca), a Tier B publisher, filed this report on .
Signal breakdown
CurrentWire ranked this story 61.7 of 100 in the snapshot this page was rendered from.
- Freshness
- 32.2 of 35
- Source authority
- 14 of 20
- Coverage breadth
- 4 of 20
- Geographic relevance
- 3.5 of 10
- Story prominence
- 8 of 10
- Velocity
- 0 of 5
Strongest signal: freshness, 32.2 of 35. How each signal is calculated.
Filed under Health · International · News. Topics extracted from this report, with other live CurrentWire stories mentioning each: Ervebo Ebola (none).
CurrentWire is a news discovery platform. This page summarizes and links to original reporting; full articles, imagery and copyright remain with the publishers listed above.